Cargando…
Enzymatic liver function measured by LiMAx – a reliable diagnostic and prognostic tool in chronic liver disease
Chronic liver disease (CLD) is a major cause of morbidity and mortality worldwide. Non-invasive assessment of hepatic disease severity represents a relevant issue to further improve clinical management and therapeutic treatment. We retrospectively compared the diagnostic and prognostic performance o...
Autores principales: | Buechter, Matthias, Kersting, Sarah, Gerken, Guido, Kahraman, Alisan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6753134/ https://www.ncbi.nlm.nih.gov/pubmed/31537822 http://dx.doi.org/10.1038/s41598-019-49746-1 |
Ejemplares similares
-
Liver maximum capacity (LiMAx) test as a helpful prognostic tool in acute liver failure with sepsis: a case report
por: Buechter, Matthias, et al.
Publicado: (2018) -
Enzymatic liver function measured by LiMAx is superior to current standard methods in predicting transplant-free survival after TIPS implantation
por: Rashidi-Alavijeh, Jassin, et al.
Publicado: (2021) -
LiMAx Prior to Radioembolization for Hepatocellular Carcinoma as an Additional Tool for Patient Selection in Patients with Liver Cirrhosis
por: Leyh, Catherine, et al.
Publicado: (2022) -
The LiMAx Test as Selection Criteria in Minimally Invasive Liver Surgery
por: Rahimli, Mirhasan, et al.
Publicado: (2022) -
Dosing of Antimycotic Treatment in Sepsis–Induced Liver Dysfunction by Functional Liver Testing with LiMAx®
por: Kirchner, Carmen, et al.
Publicado: (2019)